I’d love an update this week! Something along the lines of an OffTake agreement for 10yrs with a fixed price way above current prices, and a finance agreement for the upgrading of the Ore and scoping study.. come on Russ!!
Just bought in here. Pharma Tech business with 15m Market cap, production update due any day after increasing capacity for production, sitting well below actual value. strong buy.
Just seems odd that they are adamant from reading the LSE rules and have had their corporate actions team on it and have refused to budge their opinion..heads will roll in the corporate dept if they have got this wrong surely!
That’s it then all the excitement over for now, until the next KRS RNS re the ‘ancillary paperwork’ lands and tells us how much cash flow we’ll be seeing in the new year?
CAI wise I’d imagine they’re gonna be flatlining for a while until large upgrade in resource or the bank able feasibility study/funding agreement sorted..
Now CAI is separate from KRS are we going to have to stop talking about them on here??
“ Eligible shareholders will be entitled to receive 1 Calidus Share for every 3.451963 New Ordinary Shares registered in their name on the record date, which has been confirmed to be 6.00 pm on 19 November 2019.“
I've just got off the phone to HL, have had to forward them the RNS from weds this week so they fully understand the story. Think this is complicated even for them!! I've asked the corporate actions dept to read up clarify and send out info...if they do it or not is another matter.